PanGen Biotech, an affiliate of Huons Group, posted a surge in operating profit in 2025, rising 47.6 percent to 1.51 billion won ($1 million).
PanGen Biotech reported record revenue of 14.67 billion won ($10.2 million) in 2024.
Korea JoongAng Daily Sitemap
